市場調查報告書
商品編碼
922151
全球葡萄糖胺市場:成長,趨勢,及預測Glucosamine Market - Growth, Trends, and Forecasts (2022 - 2027) |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
全球葡萄糖胺市場在預測期間內預計將以3.8%的年複合成長率擴大。葡萄糖胺是用於治療膝蓋骨關節炎的常見補充劑。在美國,葡萄糖胺在法律上被認為是膳食補充劑。但是,歐洲需要處方。這些地區一般人久坐的生活方式習慣的增加,骨和關節的狀態的惡化,這推動了葡萄糖胺和其他據說對骨骼和關節有益的補品市場成長。
本報告提供全球葡萄糖胺市場的相關調查,提供市場機會和趨勢,成長及阻礙因素,各用途·各地區的市場分析,競爭情形,主要企業的簡介等資訊。
The Global Glucosamine Market is projected to register a CAGR of 3.8% over the forecast period (2020-2025). Glucosamine is a common supplement used for the treatment of knee osteoarthritis.
The World Health Organization (WHO) has estimated that almost 22 million individuals in Europe and 14 million in the United States alone will be suffering from osteoporosis. In 2017, it was observed that more than 200 million people suffered from osteoporosis. Bone and Joint Health Supplements target the aging population and the percentage of population above the age of 65 is significantly high in regions such as North America and Europe. Maintaining a healthy lifestyle and preventing age-related bone diseases particularly at an older age is making consumers pay premium prices for these supplements, as they impart health benefits, targeting treatment of a specific segment of the human body. This trend is certainly continuing, with the rise of simpler, cleaner, and free-from label bone and joint health supplements, as an indicator of the increase in the popularity and acceptance of the natural products. The essential properties of glucosamine have encouraged the manufacturers to introduce new products and thus, lead to the overall growth of the glucosamine market. For instance, global wellness and direct sales leader XANGO launched Xango Aeries Marine Collagen Complex, which is a blend of pure hydrolyzed marine collagen peptides with hyaluronic acid, glucosamine, vitamin C, and traditional herbs to promote healthy skin, hair, joints, and bones.
Europe has several factors conducive to the growth of the glucosamine market. The region has the highest number of people living with osteoarthritis. The World Health Organization (WHO) estimates that between 10% to 15% of the population aged 60 years and above have some form of osteoarthritis. Also, the awareness level of the general population towards health and wellness supplements, especially those used for bone and joint health are high. These factors are increasingly driving the market for glucosamine in the region.
The Global Glucosamine Market is fragmented with global companies competing fiercely with local companies to gain market share. The companies active in the market are not only looking for organic growth through product innovations and geographical expansion, but are also on the lookout for opportunistic acquistions.